Based on the important role of PI3K/AKT in platelet signaling and the observed inhibitory effect of fascaplysin on this pathway in cancer cells, we herein hypothesized that fascaplysin may exert potent anti-thrombotic activity. This evidence concerns the gene AKT1 and cancer.